Viktor Steimle

Viktor Steimle


Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2008 in Immunity
Verified
Journal Article
Closed access
JTJenny P.-Y. Ting
Jenny P.-Y. Ting
RLRuth Caroline Lovering
Ruth Caroline Lovering
EAEmad S. Alnemri
Emad S. Alnemri
JBJohn Bertin
John Bertin
JBJeremy M. Boss
Jeremy M. Boss
Peter A WardPeter A Ward
Peter A Ward

18 April 2008 in European Journal of Immunology
Verified
Journal Article
Open access
PDF file
JTJacques Thibodeau
Jacques Thibodeau
MBMarie‐Claude Bourgeois‐Daigneault
Marie‐Claude Bourgeois‐Daigneault
GHGabrielle Huppé
Gabrielle Huppé
JTJessy Tremblay
Jessy Tremblay
AAAngélique Aumont
Angélique Aumont
VSViktor Steimle
Viktor Steimle
IL‐10 is a potent anti‐inflammatory cytokine interfering with antigen presentation by inducing the intracellular sequestration of MHC class II (MHC‐II) molecules. Here we studied the contribution of membrane‐associated RING‐CH (MARCH) ubiquitin ligase family members to the IL‐10‐induced down‐regulation of MHC‐II molecules. We found that MARCH1 and MARCH8 proteins are the most potent family members for the down‐regulation of MHC‐II surface expression in transfected cells, but only MARCH1 mRNA expression is strongly induced by IL‐10 in human primary monocytes. We detected mono‐ and poly‐ubiquitinated forms of MHC‐II molecules both in IL‐10‐treated monocytes and in cells transfected with MARCH1. We also show direct interaction between MHC‐II and MARCH1 molecules in co‐immunoprecipitation assays. Finally, we found that siRNA‐mediated knockdown of MARCH1 reverses IL‐10‐induced MHC‐II down‐regulation in primary monocytes. Thus, the immunosuppressive effect of IL‐10 on antigen presentation is mediated through induced expression of MARCH1.

Verified
Journal Article
Open access
PDF file
JMJorge Alfonso León Machado
Jorge Alfonso León Machado
VSViktor Steimle
Viktor Steimle
In this review, we discuss the major histocompatibility complex (MHC) class II transactivator (CIITA), which is the master regulator of MHC class II gene expression. CIITA is the founding member of the mammalian nucleotide-binding and leucine-rich-repeat (NLR) protein family but stood apart for a long time as the only transcriptional regulator. More recently, it was found that its closest homolog, NLRC5 (NLR protein caspase activation and recruitment domain (CARD)-containing 5), is a regulator of MHC-I gene expression. Both act as non-DNA-binding activators through multiple protein–protein interactions with an MHC enhanceosome complex that binds cooperatively to a highly conserved combinatorial cis-acting module. Thus, the regulation of MHC-II expression is regulated largely through the differential expression of CIITA. In addition to the well-defined role of CIITA in MHC-II GENE regulation, we will discuss several other aspects of CIITA functions, such as its role in cancer, its role as a viral restriction element contributing to intrinsic immunity, and lastly, its very recently discovered role as an inhibitor of Ebola and SARS-Cov-2 virus replication. We will briefly touch upon the recently discovered role of NLRP3 as a transcriptional regulator, which suggests that transcriptional regulation is, after all, not such an unusual feature for NLR proteins.

21 July 2003 in European Journal of Immunology
Verified
Journal Article
Open access
PDF file
FSFelix Schnappauf
Felix Schnappauf
SHSandra B. Hake
Sandra B. Hake
MCMargarita M. Camacho Carvajal
Margarita M. Camacho Carvajal
SBSéverine Bontron
Séverine Bontron
BLBarbara Lisowska‐Grospierre
Barbara Lisowska‐Grospierre
VSViktor Steimle
Viktor Steimle
Major histocompatibility complex (MHC) class II molecules play an essential role for the cellular immune response by presenting peptide antigens to CD4+ T cells. MHC class II molecules and genes show a highly complex expression pattern, which is orchestrated through a master regulatory factor, called CIITA (class II transactivator). CIITA controls MHC class II expression not only qualitatively, but also quantitatively, and has therefore a direct influence on the CD4 T cell‐dependent immune response. CIITA is itself tightly regulated not only on the transcriptional level, but as we show here also on the protein level. CIITA is subjected to a very rapid protein turnover and shows a half‐life of about 30 min. Inhibition of degradation by proteasome inhibitors and the identification of ubiquitylated CIITA intermediates indicate that the degradation of CIITA is mediated by the ubiquitin‐proteasome system. We identified two regions mediating degradation within the N‐terminal domain of CIITA. N‐terminal fusions or deletions stabilized CIITA, indicating that the N termini contribute to degradation. Several non‐functional CIITA mutants are partially stabilized, but we provide evidence that transcriptional activity of CIITA is not directly linked to degradation.

1 January 2004 in International Immunology
Verified
Journal Article
Open access
PDF file
MCMargarita M. Camacho‐Carvajal
Margarita M. Camacho‐Carvajal
SKSebastian Klingler
Sebastian Klingler
FSFelix Schnappauf
Felix Schnappauf
SHSandra B. Hake
Sandra B. Hake
VSViktor Steimle
Viktor Steimle
Class II transactivator (CIITA), the master regulator of MHC class II (MHC‐II) gene transcription, shows a complex behavior in terms of self‐association, nucleo‐cytoplasmic transport and MHC‐II gene transactivation. Here, we analyzed the mechanisms of dominant‐negative function and nucleo‐cytoplasmic transport of CIITA with emphasis on the role of the C‐terminal leucine‐rich‐repeat (LRR) region in these processes. First, we determined nucleo‐cytoplasmic transport of endogenous CIITA and thus validated results obtained with epitope‐tagged CIITA constructs. LRR mutations in potential protein–protein contact positions lead to either completely blocked or reduced nuclear import, but can also give rise to increased nuclear export. Surprisingly, N‐terminally truncated CIITA mutants show dominant‐negative inhibition of wild‐type CIITA, whether they are located in the nucleus or in the cytoplasm. Integrity of the LRR is necessary for the dominant‐negative function of both types of mutants. LRR mutations are dominant over the effect of an exogenously added N‐terminal nuclear localization signal (NLS) leading to cytoplasmic localization. Taken together, our results show that the LRR regulate the function of one or several NLS within CIITA, and control both nuclear import and export. Self‐association is not affected in these mutants; we therefore suggest that interaction of the LRR with an unknown protein partner may be necessary for import and transactivation function of CIITA.

12 February 2016 in PLOS ONE
Verified
Journal Article
Open access
PDF file
YBYves B. Beaulieu
Yves B. Beaulieu
JMJorge A. Leon Machado
Jorge A. Leon Machado
SESylvain Ethier
Sylvain Ethier
LGLuc Gaudreau
Luc Gaudreau
VSViktor Steimle
Viktor Steimle
Multiple relationships between ubiquitin-proteasome mediated protein turnover and transcriptional activation have been well documented, but the underlying mechanisms are still poorly understood. One way to induce degradation is via ubiquitination of the N-terminal α-amino group of proteins. The major histocompatibility complex (MHC) class II transactivator CIITA is the master regulator of MHC class II gene expression and we found earlier that CIITA is a short-lived protein. Using stable and transient transfections of different CIITA constructs into HEK-293 and HeLa cell lines, we show here that the extreme N-terminal end of CIITA isoform III induces both rapid degradation and transactivation. It is essential that this sequence resides at the N-terminal end of the protein since blocking of the N-terminal end with an epitope-tag stabilizes the protein and reduces transactivation potential. The first ten amino acids of CIITA isoform III act as a portable degron and transactivation sequence when transferred as N-terminal extension to truncated CIITA constructs and are also able to destabilize a heterologous protein. The same is observed with the N-terminal ends of several known N-terminal ubiquitination substrates, such as Id2, Cdt1 and MyoD. Arginine and proline residues within the N-terminal ends contribute to rapid turnover. The N-terminal end of CIITA isoform III is responsible for efficient in vivo recruitment to the HLA-DRA promoter and increased interaction with components of the transcription machinery, such as TBP, p300, p400/Domino, the 19S ATPase S8, and the MHC-II promoter binding complex RFX. These experiments reveal a novel function of free N-terminal ends of proteins in degradation-dependent transcriptional activation.